The U.S. Ophthalmic Clinical Trials Market was valued at USD 0.66 Billion in 2025 and is projected to reach USD 1.25 Billion by 2035, while Europe is expected to grow from USD 0.49 Billion to USD 0.89 Billion during the forecast period, driven by expanding retinal disease pipelines and ophthalmic innovation.
The U.S. Ophthalmic Clinical Trials Market was valued at USD 0.66 Billion in 2025 and is projected to reach USD 1.25 Billion by 2035, while Europe is expected to grow from USD 0.49 Billion to USD 0.89 Billion during the forecast period, driven by expanding retinal disease pipelines and ophthalmic innovation.